Member Info for bidnolid

It's a perfect environment to release a lung cancer test into .. they just need to get on with it now

Well I timed my initial purchase perfectly lol. That's why I never buy the target full amount straight away!

NT to sell anything at the moment so it's going to plop under 0.3

Well I've had a little nibble at 0.302, might buy some more as I do more research. Could have bought up to 5 according to my broker, plenty on the bid

What's the most likely near term news on this one please? Doing some digging before maybe buying a few

Can't even buy 10 shares on AJ Bell ffs

52p

Not surprising it's plopping really.. no RNS to add substance. CIZ has a spike every year and always drops back as there's never anything tangible to back it up

Ok thanks for the responses, I've clearly not grasped the science part properly.. every time I listen to a Syms DT interview I nod off

Still a big question mark for me is Omni Health. My understanding that they are not actually producing the test, they are just helping to validate it? According to my searches they only have around 350k revenue and are extremely small. It does say in the RNS that Bio will "add further clinical laboratory partners as required to be able to meet anticipated market demand" so can only hope a larger partner comes on to take the reins

Well, still nobody has any idea about the potential revenues. Both feet in the 3's now this needs an RNS to justify the rise

I know there are upfront royalties being paid to Ciz from Ciz Bio, but can anyone tell me what % of sales Ciz will get once this (hopefully) starts being sold commercially?

100k max at 2.86 now.. really flying. Needs substance behind it though or it'll be back down like usual

I wouldn't pay much attention to the ned appointments, I've never seen a non exec at an AIM listed company do anything of note. The people who will put a fire under the CEO's a*se is Peter Gyllenhammar and the chap from Harwood who own almost 30% between them. They must be pushing for some action soon, this is not really worth the ongoing listing costs. As you say, the strategy for growth is pinning their hopes on a recovery that never seems to materialise and this mid east conflict is not going to help matters

Well there's no quote available to buy so that's great..

If a company has to RNS its "2025 achievements" you know they are wasting your time. Been trawling Nuvec around for years and nobody is interested .. it's just a glorified university project, not an investment

Is 2026 the year that Van Elle finally deliver.. much more positive TU

Someone needs to step in and shut this down. David can't hear the fat lady singing

Is this the news people were hoping for?

What you guys expecting? This Bill Bennie fella seems to be running off with AS's lunch